[Ulcerative colitis and Crohn's disease].

  • Matsuoka K
  • Hibi T
  • 5

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Author-supplied keywords

  • Animals
  • Anti-Bacterial Agents
  • Anti-Bacterial Agents: therapeutic use
  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Antineutrophil Cytoplasmic: blood
  • Antibodies, Fungal
  • Antibodies, Fungal: blood
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal: therapeutic use
  • Appendectomy
  • Biomarkers
  • Biomarkers: blood
  • Colitis, Ulcerative
  • Colitis, Ulcerative: diagnosis
  • Colitis, Ulcerative: etiology
  • Colitis, Ulcerative: physiopathology
  • Colitis, Ulcerative: therapy
  • Crohn Disease
  • Crohn Disease: diagnosis
  • Crohn Disease: etiology
  • Crohn Disease: physiopathology
  • Crohn Disease: therapy
  • Diagnosis, Differential
  • Humans
  • Immunosuppressive Agents
  • Immunosuppressive Agents: therapeutic use
  • Infliximab
  • Intestines
  • Intestines: microbiology
  • Intracellular Signaling Peptides and Proteins
  • Intracellular Signaling Peptides and Proteins: gen
  • Intracellular Signaling Peptides and Proteins: phy
  • Mesalamine
  • Mesalamine: therapeutic use
  • Mutation
  • Nod2 Signaling Adaptor Protein
  • Probiotics
  • Probiotics: therapeutic use
  • Saccharomyces cerevisiae
  • Saccharomyces cerevisiae: immunology
  • Tumor Necrosis Factor-alpha
  • Tumor Necrosis Factor-alpha: immunology

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Katsuyoshi Matsuoka

  • Toshifumi Hibi

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free